406 related articles for article (PubMed ID: 11920526)
1. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
3. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.
Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS
J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
[TBL] [Abstract][Full Text] [Related]
6. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in operating characteristics of prostate cancer screening tests.
Smith DS; Bullock AD; Catalona WJ
J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
10. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
Eastham JA; Carver B; Katz J; Kattan MW
Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
[TBL] [Abstract][Full Text] [Related]
11. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.
Freedland SJ; Jalkut M; Dorey F; Sutter ME; Aronson WJ
Urology; 2000 Jul; 56(1):87-91. PubMed ID: 10869631
[TBL] [Abstract][Full Text] [Related]
12. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA
JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.
Presti JC; Hovey R; Bhargava V; Carroll PR; Shinohara K
J Urol; 1997 Mar; 157(3):907-11; discussion 911-2. PubMed ID: 9072597
[TBL] [Abstract][Full Text] [Related]
14. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
Fowler JE; Bigler SA; Kilambi NK; Land SA
Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics in black and white men with prostate cancer in an equal access medical center.
Freedland SJ; Sutter ME; Naitoh J; Dorey F; Csathy GS; Aronson WJ
Urology; 2000 Mar; 55(3):387-90. PubMed ID: 10699616
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
17. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
18. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
[TBL] [Abstract][Full Text] [Related]
19. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
20. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
Fowler JE; Bigler SA; Bowman G; Kilambi NK
J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
